FR2034535A1 - - Google Patents

Info

Publication number
FR2034535A1
FR2034535A1 FR7004757A FR7004757A FR2034535A1 FR 2034535 A1 FR2034535 A1 FR 2034535A1 FR 7004757 A FR7004757 A FR 7004757A FR 7004757 A FR7004757 A FR 7004757A FR 2034535 A1 FR2034535 A1 FR 2034535A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7004757A
Other versions
FR2034535B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck KGaA
Original Assignee
Merck KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck KGaA filed Critical Merck KGaA
Publication of FR2034535A1 publication Critical patent/FR2034535A1/fr
Application granted granted Critical
Publication of FR2034535B1 publication Critical patent/FR2034535B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R4/00—Electrically-conductive connections between two or more conductive members in direct contact, i.e. touching one another; Means for effecting or maintaining such contact; Electrically-conductive connections having two or more spaced connecting locations for conductors and using contact members penetrating insulation
    • H01R4/02—Soldered or welded connections
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R9/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, e.g. terminal strips or terminal blocks; Terminals or binding posts mounted upon a base or in a case; Bases therefor
    • H01R9/22—Bases, e.g. strip, block, panel
    • H01R9/28—Terminal boards

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR707004757A 1969-02-11 1970-02-11 Expired FR2034535B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1906586A DE1906586C3 (de) 1969-02-11 1969-02-11 9 alpha-Fluor-16-fluormethylenprednisolon-21-önanthat, Verfahren zu seiner Herstellung und diese enthaltende pharmazeutische Zubereitung

Publications (2)

Publication Number Publication Date
FR2034535A1 true FR2034535A1 (fr) 1970-12-11
FR2034535B1 FR2034535B1 (fr) 1973-01-12

Family

ID=5724819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR707004757A Expired FR2034535B1 (fr) 1969-02-11 1970-02-11

Country Status (15)

Country Link
US (1) US3681409A (fr)
AT (3) AT303277B (fr)
BE (1) BE745708A (fr)
BR (1) BR6915196D0 (fr)
CH (1) CH534673A (fr)
DE (1) DE1906586C3 (fr)
DK (1) DK123475B (fr)
ES (1) ES376409A1 (fr)
FR (1) FR2034535B1 (fr)
GB (1) GB1247641A (fr)
HU (1) HU165223B (fr)
IL (1) IL33812A (fr)
NL (1) NL7001197A (fr)
PL (1) PL80839B1 (fr)
SE (1) SE356744B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
TW201914575A (zh) * 2017-09-19 2019-04-16 大江生醫股份有限公司 地龍蛋白用於製造調理皮膚醫藥組成物之用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH405306A (de) * 1959-02-10 1966-01-15 Ciba Geigy Verfahren zur Herstellung von Pregnadienverbindungen
DE1177151B (de) * 1961-06-08 1964-09-03 Merck Ag E Verfahren zur Herstellung von 16-Chlormethylen- bzw. 16-Brommethylen-steroiden

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
DE1906586A1 (de) 1970-11-05
FR2034535B1 (fr) 1973-01-12
US3681409A (en) 1972-08-01
NL7001197A (fr) 1970-08-13
GB1247641A (en) 1971-09-29
DE1906586C3 (de) 1974-01-03
DK123475B (da) 1972-06-26
BE745708A (fr) 1970-08-10
IL33812A0 (en) 1970-03-22
DE1906586B2 (de) 1973-06-07
HU165223B (fr) 1974-07-27
AT305503B (de) 1973-01-15
AT298692B (de) 1972-05-25
CH534673A (de) 1973-03-15
IL33812A (en) 1973-05-31
AT303277B (de) 1972-10-15
ES376409A1 (es) 1973-01-01
SE356744B (fr) 1973-06-04
PL80839B1 (fr) 1975-08-30
BR6915196D0 (pt) 1973-02-13

Similar Documents

Publication Publication Date Title
FR2065840A5 (fr)
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442322B2 (fr)
AU442554B2 (fr)
AU442538B2 (fr)
AU442463B2 (fr)
AU442357B2 (fr)
AU442380B2 (fr)
AU428131B2 (fr)
AU438128B2 (fr)
AU442535B2 (fr)
AU470661B1 (fr)
AU442285B2 (fr)
AU5109569A (fr)
AU4949169A (fr)
AU4540468A (fr)
AU5077469A (fr)
AU481328A (fr)
AU480213A (fr)
AU448562A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse